David R Matthews (D R Matthews, David Matthews)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 18

Top Topics

Bariatric Surgery

Glycemic Control

Systematic Review

Newly Diagnosed

Top Venues

Diabetes, obesity & metabolism

Annals of internal medicine

Diabetic medicine : a journal of the British Diabetic Association

This page only lists publications with an associated author ORCID identifier.

Publications

Ioannis Avgerinos, Thomas Karagiannis, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis. Diabetes, obesity & metabolism (2023)
Thomas Karagiannis, Ioannis Avgerinos, Aris Liakos, Stephano Del Prato, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia 65 (8) (2022)
David R Matthews
ADVANCE. Diabetes, obesity & metabolism (2021)
Ioannis Avgerinos, Apostolos Manolopoulos, Theodoros Michailidis, Konstantinos Kitsios, Aris Liakos, Thomas Karagiannis, Konstantinos Dimitrakopoulos, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis. Diabetes, obesity & metabolism 23 (3) (2021)
Johanne Tremblay, Mounsif Haloui, Redha Attaoua, Muhammad Ramzan Tahir, Camil Hishmih, François Harvey, François-Christophe Marois-Blanchet, Carole Long, Paul Simon, Lara Santucci, Candan Hizel, John Chalmers, Michel Marre, Stephen B Harrap, Renata Cífková, Alena Krajčoviechová, David R Matthews, Bryan Williams, Neil R Poulter, Sophia Zoungas, Stephen Colagiuri, Giuseppe Mancia, Diederick E Grobbee, Anthony Rodgers, Liusheng Liu, Mawussé Agbessi, Vanessa Bruat, Marie-Julie Favé, Michelle P Harwood, Phillip Awadalla, Mark Woodward, Julie G Hussin, Pavel Hamet
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control. Diabetologia 64 (9) (2021)
Ioannis Avgerinos, Georgia Papanastasiou, Thomas Karagiannis, Theodoros Michailidis, Aris Liakos, Maria Mainou, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 23 (10) (2021)
Ioannis Avgerinos, Thomas Karagiannis, Panagiota Kakotrichi, Theodoros Michailidis, Aris Liakos, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 24 (1) (2021)
Apostolos Tsapas, Thomas Karagiannis, Panagiota Kakotrichi, Ioannis Avgerinos, Chrysanthi Mantsiou, Georgios Tousinas, Apostolos Manolopoulos, Aris Liakos, Konstantinos Malandris, David R Matthews, Apostolos Tsapas
Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis. Diabetes, obesity & metabolism 23 (9) (2021)
Apostolos Tsapas, Thomas Karagiannis, Ioannis Avgerinos, David R Matthews
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes. Annals of internal medicine 174 (1) (2021)
Prasad Katulanda, Harsha Anuruddhika Dissanayake, Ishara Ranathunga, Ratnasamy Vithiya, Piyumi Sachindra Alwis Wijewickrama, Nilukshana Yogendranathan, Kavinga Kalhari Kobawaka Gamage, Nipun L de Silva, Manilka Sumanatilleke, Noel Pratheepan Somasundaram, David R Matthews
Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature. Diabetologia 63 (8) (2020)
David R Matthews, Stefano Del Prato, Viswanathan Mohan, Chantal Mathieu, Sergio Vencio, Juliana C N Chan, Michael Stumvoll, Päivi Maria Paldánius
Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (11) (2020)
Juliana Chung Ngor Chan, Päivi M Paldánius, Chantal Mathieu, Michael Stumvoll, David R Matthews, Stephano Del Prato
Early combination therapy delayed treatment escalation in newly diagnosed young-onset type 2 diabetes: A subanalysis of the VERIFY study. Diabetes, obesity & metabolism 23 (1) (2020)
Apostolos Tsapas, Ioannis Avgerinos, Thomas Karagiannis, Konstantinos Malandris, Apostolos Manolopoulos, Panagiotis Andreadis, Aris Liakos, David R Matthews, Eleni Bekiari
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Annals of internal medicine 173 (4) (2020)
Toshiaki Ohkuma, Luc Van Gaal, Wayne Shaw, Kenneth W Mahaffey, Dick de Zeeuw, David R Matthews, Vlado Perkovic, Bruce C Neal
Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program. Diabetes, obesity & metabolism 22 (4) (2020)
David R Matthews, Carol H Wysham, Melanie Jane Davies, April Slee, Maria Alba, Mary Lee, Vlado Perkovic, Kenneth W Mahaffey, Bruce C Neal
Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program. Diabetes, obesity & metabolism 22 (11) (2020)
Ioannis Avgerinos, Theodoros Michailidis, Aris Liakos, Thomas Karagiannis, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 22 (3) (2019)
David R Matthews, P M Paldánius, P Proot, J E Foley, M Stumvoll, S Del Prato
Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association 36 (4) (2019)
David R Matthews, Päivi M Paldánius, Michael Stumvoll, Jackie Han, Giovanni Bader, YannTong Chiang, Pieter Proot, Stephano Del Prato
A pre-specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM. Diabetes, obesity & metabolism 21 (10) (2019)